LIPIL line complete
This article was originally published in The Tan Sheet
Executive Summary
Enfacare LIPIL, intended for premature babies after they leave the hospital, rounds out Mead Johnson's ARA-, DHA-fortified infant formula line, BMS subsidiary announces Aug. 20. Line extension contains same levels of docosahexaenoic acid, arachidonic acid as Enfamil LIPIL preterm, term formulas, but differs in fat levels. Enfacare, which will reach shelves in late summer/early fall, is line-priced with other two LIPIL products and will retail for about 10%-15% more than original Enfacare formulas. Firm also plans to give free cases of Enfamil LIPIL with Iron to mothers who give birth on Labor Day...
You may also be interested in...
Similac Advance preterm extension
Abbott Labs division Ross Products to launch three preterm formulas: NeoSure Advance, Similac Special Care and Similac Natural Care. Infant formulas are fortified with docosahexaenoic and arachidonic acids, complement firm's DHA- and ARA-fortified Similac Advance for term infants. New formulas, hitting shelves this month, will compete with Mead Johnson's recently completed Enfamil LIPIL line; BMS division launched enriched Enfacare in August (1"The Tan Sheet" Aug. 26, 2002, In Brief)...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.